Search for: "HORIZON" Results 421 - 440 of 10,974
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Sep 2023, 10:00 pm
As fiscal year 2024 approaches, a partial government shutdown looms on the horizon once more. [read post]
26 Sep 2023, 9:00 pm by News Desk
In 2021, EREN members discussed 35 signals and potential emerging issues identified by their own horizon-scanning activities. [read post]
25 Sep 2023, 10:00 pm
FDA’s Center for Biologics Evaluation and Research (CBER), the locus of regulating cell and gene therapies among other expanding areas of biotech, is poised for change on a number of important fronts—leadership, significant growth, and plans to address challenging scientific and regulatory issues. [read post]
25 Sep 2023, 10:00 pm
FDA’s Center for Biologics Evaluation and Research (CBER), the locus of regulating cell and gene therapies among other expanding areas of biotech, is poised for change on a number of important fronts—leadership, significant growth, and plans to address challenging scientific and regulatory issues. [read post]
25 Sep 2023, 10:00 pm
FDA’s Center for Biologics Evaluation and Research (CBER), the locus of regulating cell and gene therapies among other expanding areas of biotech, is poised for change on a number of important fronts—leadership, significant growth, and plans to address challenging scientific and regulatory issues. [read post]
25 Sep 2023, 10:00 pm
FDA’s Center for Biologics Evaluation and Research (CBER), the locus of regulating cell and gene therapies among other expanding areas of biotech, is poised for change on a number of important fronts—leadership, significant growth, and plans to address challenging scientific and regulatory issues. [read post]
25 Sep 2023, 10:00 pm
FDA’s Center for Biologics Evaluation and Research (CBER), the locus of regulating cell and gene therapies among other expanding areas of biotech, is poised for change on a number of important fronts—leadership, significant growth, and plans to address challenging scientific and regulatory issues. [read post]
25 Sep 2023, 10:00 pm
FDA’s Center for Biologics Evaluation and Research (CBER), the locus of regulating cell and gene therapies among other expanding areas of biotech, is poised for change on a number of important fronts—leadership, significant growth, and plans to address challenging scientific and regulatory issues. [read post]
24 Sep 2023, 4:58 am by Jonathan Bench
China will remain critical, but it’s time for sourcing teams to expand their horizons by taking steps to put their company in the strongest possible position for the future. [read post]
24 Sep 2023, 4:58 am by Jonathan Bench
China will remain critical, but it’s time for sourcing teams to expand their horizons by taking steps to put their company in the strongest possible position for the future. [read post]
23 Sep 2023, 5:28 am by rickgeorges
Google may have been taken by surprise by ChatGPT, and many of us are using ChatGPT every day in our practices; but Google is not a company to rest on its laurels; especially with an existential threat on the horizon. [read post]
22 Sep 2023, 7:46 am by Robert Guest
If you and your spouse get along but know divorce is on the horizon, a Forney divorce lawyer at Guest & Gray may be able to help keep the tension-level low. [read post]
22 Sep 2023, 6:30 am
Posted by the Harvard Law School Forum on Corporate Governance, on Friday, September 22, 2023 Editor's Note: This roundup contains a collection of the posts published on the Forum during the week of September 15-21, 2023 Financial Implications of Rising Political Risk in the US Posted by Stephen Davis (Harvard Law School), on Friday, September 15, 2023 Tags: C+C, CEOs, Presidential elections, US institutions In 2022, Corporate Time Horizons Shorten, Investors’ Lengthen… [read post]
22 Sep 2023, 6:30 am
Posted by the Harvard Law School Forum on Corporate Governance, on Friday, September 22, 2023 Editor's Note: This roundup contains a collection of the posts published on the Forum during the week of September 15-21, 2023 Financial Implications of Rising Political Risk in the US Posted by Stephen Davis (Harvard Law School), on Friday, September 15, 2023 Tags: C+C, CEOs, Presidential elections, US institutions In 2022, Corporate Time Horizons Shorten, Investors’ Lengthen… [read post]
With emerging treatments on the horizon, the attention shifts towards benefits accommodating evolving medical interventions. [read post]
21 Sep 2023, 5:56 pm by Michel-Adrien
By reflecting on what might happen in the future, Policy Horizons Canada aims to strengthen decision making within the Government of Canada"The report was written by Policy Horizons Canada, an organization within the federal public service that conducts strategic foresight research. [read post]
20 Sep 2023, 5:50 am by Rob Robinson
Avalon Broadens Managed Review Horizon with Tower Legal Solutions Acquisition On August 28, 2023, Surge PE announced the addition of Tower Legal Solutions to its Avalon platform. [read post]
19 Sep 2023, 7:45 pm by Sabrina I. Pacifici
But today, Americans’ views of politics and elected officials are unrelentingly negative, with little hope of improvement on the horizon. [read post]